UBS (UBS) 6-KCurrent report (foreign)
Filed: 13 Sep 22, 6:30am
UNITED STATES
SECURITIES AND EXCHANGE COMMISSION
Washington, D.C. 20549
_________________
FORM 6-K
REPORT OF FOREIGN PRIVATE ISSUER
PURSUANT TO RULE 13a-16 OR 15d-16 UNDER
THE SECURITIES EXCHANGE ACT OF 1934
Date: September 13, 2022
UBS Group AG
Commission File Number: 1-36764
UBS AG
Commission File Number: 1-15060
(Registrants' Names)
Bahnhofstrasse 45, Zurich, Switzerland, and
Aeschenvorstadt 1, Basel, Switzerland
(Address of principal executive offices)
Indicate by check mark whether the registrants file or will file annual reports under cover of
Form 20‑F or Form 40-F.
Form 20-F x Form 40-F o
Investor Relations
Tel. +41-44-234 41 00
Media Relations
Tel. +41-44-234 85 00
13 September 2022 |
News Release |
Ad hoc announcement pursuant to Article 53 of the SIX Exchange Regulation Listing Rules
UBS provides update to its 2022 capital returns to shareholders |
UBS to accrue for anticipated 2022 dividend of USD 0.55 per share; anticipates share repurchases will exceed USD 5bn for 2022 |
Zurich/Basel, 13 September 2022 – UBS will adjust its accrual for the 2022 ordinary dividend from USD 0.51 to USD 0.55 per share – an increase of 10% compared to the previous year. The Board intends to propose the dividend for approval by shareholders at the Annual General Meeting to be held in 2023.
In addition, UBS expects share repurchases to exceed the USD 5bn goal for the year 2022. As of 9 September 2022, UBS has bought back USD 4.1bn of shares.
We will provide guidance on next year’s capital return at our fourth quarter earnings presentation and expect to continue to have share repurchases and a progressive dividend.
UBS Group AG and UBS AG
Investor Relations:
Switzerland:
Media Relations: | +41-44-234 41 00 |
Switzerland: | +41-44-234 85 00 |
UK: | +44-207-567 47 14 |
Americas: | +1-212-882 58 58 |
APAC: | +852-297-1 82 00 |
www.ubs.com/media
Investor Relations
Tel. +41-44-234 41 00
Media Relations
Tel. +41-44-234 85 00
Forward-Looking Statements
This media release contains statements that constitute “forward-looking statements,” including but not limited to management’s outlook for UBS’s financial performance, statements relating to the anticipated effect of transactions and strategic initiatives on UBS’s business and future development and goals or intentions to achieve climate, sustainability and other social objectives. While these forward-looking statements represent UBS’s judgments, expectations and objectives concerning the matters described, a number of risks, uncertainties and other important factors could cause actual developments and results to differ materially from UBS’s expectations. For a discussion of the risks and uncertainties that may affect UBS's future results please refer to the "Risk Factors" and other sections of UBS’s most recent Annual Report on Form 20-F, quarterly reports and other information furnished to or filed with the US Securities and Exchange Commission on Form 6-K, and the cautionary statement on the last page of this presentation. UBS is not under any obligation to (and expressly disclaims any obligation to) update or alter its forward-looking statements, whether as a result of new information, future events, or otherwise.
This Form 6-K is hereby incorporated by reference into (1) each of the registration statements of UBS AG on Form F-3 (Registration Number 333-263376), and of UBS Group AG on Form S-8 (Registration Numbers 333-200634; 333-200635; 333-200641; 333-200665; 333-215254; 333-215255; 333-228653; 333-230312; and 333-249143), and into each prospectus outstanding under any of the foregoing registration statements, (2) any outstanding offering circular or similar document issued or authorized by UBS AG that incorporates by reference any Forms 6-K of UBS AG that are incorporated into its registration statements filed with the SEC, and (3) the base prospectus of Corporate Asset Backed Corporation (“CABCO”) dated June 23, 2004 (Registration Number 333-111572), the Form 8-K of CABCO filed and dated June 23, 2004 (SEC File Number 001-13444), and the Prospectus Supplements relating to the CABCO Series 2004-101 Trust dated May 10, 2004 and May 17, 2004 (Registration Number 033-91744 and 033-91744-05).
SIGNATURES
Pursuant to the requirements of the Securities Exchange Act of 1934, the registrants have duly caused this report to be signed on their behalf by the undersigned, thereunto duly authorized.
UBS Group AG
By: _/s/ David Kelly______________
Name: David Kelly
Title: Managing Director
By: _/s/ Ella Campi_______________
Name: Ella Campi
Title: Executive Director
UBS AG
By: _/s/ David Kelly______________
Name: David Kelly
Title: Managing Director
By: _/s/ Ella Campi_______________
Name: Ella Campi
Title: Executive Director
Date: September 13, 2022